Horizon Technology Finance Corporation (HRZN) insider have most recently took part in a trading activity. On Nov 28, 2017 Pomeroy Robert D. Jr., CEO bought 800 shares having total worth of $8,856 at the price of $11.07 per share, following the transaction a total of 72,548 shares owned by Pomeroy Robert D. Jr..
Furthermore, over the past 12 months , the stock was traded 2 times by insiders. an employee of the company was the buyer in 2 instances.
Shares of Horizon Technology Finance Corporation (HRZN) traded down 0.9% on Nov 27, 2017, hitting $11.03. 27,612 shares of the company’s stock traded hands. Horizon Technology Finance Corporation has a 52 week low of $9.83 and a 52 week high of $13.86. The company’s market cap is $157 million.
Horizon Technology Finance Corporation (HRZN) last announced its earnings results on Oct 31, 2017. The company reported 0.33 earnings per share (EPS) for the quarter, higher than the consensus estimate of 0.28 by $0.05. The company had revenue of $7 million for the quarter, compared to the consensus estimate of $6 million. During the same quarter in the previous year, the company posted 0.38 earnings per share. The company’s revenue for the quarter was down 11% on a year-over-year basis.
|earnings per share||0.33||0.24||0.29||0.33||0.38||0.39||0.38||0.35||0.35||0.25|
Horizon Technology Finance Corp was incorporated in the state of Delaware in the year 2010 and it is an externally managed, non-diversified, closed end investment company. The company is a specialty finance company that lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and cleantech industries, which refer to as ‘Target Industries.’ Its investment objective is to generate current income from the loans the company make and capital appreciation from the warrants it receives when making such loans. The company makes secured loans, which refer to as ‘Technology Loans,’ to companies backed by established venture capital and private equity firms in its Target Industries, which refer to as ‘Technology Lending.’ The company also selectively lend to publicly traded companies in its Target Industries. The company is externally managed and advised by Advisor, Horizon Technology Finance Management LLC. Interest on loan investments is accrued and included in income based on contractual rates applied to principal amounts outstanding. The company receives a variety of fees from borrowers in the ordinary course of conducting its business, including advisory fees, commitment fees, amendment fees, non-utilization fees and prepayment fees. Its advisor employing the following core strategies: Structured Investments in the Venture Capital and Private Equity Markets: The company make loans to development-stage companies within Target Industries typically in the form of secured amortizing loans, the secured amortizing debt structure provides a lower risk strategy, as compared to equity investments, to participate in the emerging technology markets, because the debt structures it typically utilize provide collateral against the downside risk of loss; ‘Enterprise Value’ Lending: It take an enterprise value approach to the loan structuring and underwriting process; Creative Products with Attractive Risk-Adjusted Pricing: Each of existing and prospective portfolio companies has its own unique funding needs for the capital provided from the proceeds of its Technology Loans; Direct Origination: The company originate transactions directly with technology, life science, healthcare information and services, and cleantech companies. The company has identified several criteria that it believes proven, and will prove, important in achieving investment objective which includes Portfolio Composition: It make investments in companies that are diversified by their stage of development, their Target Industries and sectors of Target Industries, and their geographical location, as well as by the venture capital and private equity sponsors; Company Stage of Development: While invest in companies at various stages of development, it require that prospective portfolio companies be beyond the seed stage of development and have received at least their first round of venture capital or private equity finan
Latest posts by William White (see all)
- Insider Trading Activity in: Second Sight Medical Products, Inc. $EYES - July 19, 2018
- Insider Trading Activity in: Internationa Flavors & Fragrances, Inc. $IFF - July 19, 2018
- Insider Trading Update: Opko Health, Inc. $OPK - July 19, 2018